Finance Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billionOctober 27, 20250 Swiss drugmaker Novartis on Sunday stated it agreed to accumulate U.S. biotech agency Avidity Biosciences for about $12 billion in…
